Scancell Holdings plc

Scancell Holdings plcverified

SCNLF

Price:

$0.135

Market Cap:

$102.22M

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, an ImmunoBody cancer vaccine for the treatment of metastatic melanoma; SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumours, including non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2, which targets homocitrullinated cancer antigens. In addition, the company deve...[Read more]

Industry

Biotechnology

IPO Date

2013-08-02

Stock Exchange

OTC

Ticker

SCNLF

The PE Ratio as of December 2025 (TTM) for Scancell Holdings plc (SCNLF) is -6.75

According to Scancell Holdings plc’s latest financial reports and current stock price. The company's current PE Ratio is -6.75. This represents a change of -128.60% compared to the average of 23.60 of the last 4 quarters.

Scancell Holdings plc (SCNLF) Historical PE Ratio (quarterly & annually)

How has SCNLF PE Ratio performed in the past?

The mean historical PE Ratio of Scancell Holdings plc over the last ten years is -14.09. The current -6.75 PE Ratio has changed 4.69% with respect to the historical average. Over the past ten years (40 quarters), SCNLF's PE Ratio was at its highest in in the April 2025 quarter at 112.89. The PE Ratio was at its lowest in in the September 2013 quarter at -22.23.

Quarterly (TTM)
Annual

Average

-14.09

Median

-9.37

Minimum

-56.24

Maximum

-3.61

Scancell Holdings plc (SCNLF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Scancell Holdings plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 483.03%

Maximum Annual PE Ratio = -3.61

Minimum Annual Increase = -81.00%

Minimum Annual PE Ratio = -56.24

Quarterly (TTM)
Annual
YearPE RatioChange
2025-8.50-35.27%
2024-13.1322.91%
2023-10.68-81.00%
2022-56.24483.03%
2021-9.6542.76%
2020-6.7687.06%
2019-3.61-60.27%
2018-9.090.66%
2017-9.03-36.38%
2016-14.20-43.01%

Scancell Holdings plc (SCNLF) Average PE Ratio

How has SCNLF PE Ratio performed in the past?

The current PE Ratio of Scancell Holdings plc (SCNLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-10.77

5-year avg

-19.64

10-year avg

-14.09

Scancell Holdings plc (SCNLF) PE Ratio vs. Peers

How is SCNLF’s PE Ratio compared to its peers?

Scancell Holdings plc’s PE Ratio is less than Botanix Pharmaceuticals Limited (-2.60), less than Innate Pharma S.A. (-3.11), greater than NDT Pharmaceuticals Inc. (-6745.45), less than Molecular Partners AG (-1.94), less than Brii Biosciences Limited (-2.80), less than Hofseth BioCare ASA (-4.79), less than Kintor Pharmaceutical Limited (0), less than Poolbeg Pharma PLC (-3.30), greater than NervGen Pharma Corp. (-15.79), less than Orexo AB (publ) (-4.32),

Build a custom stock screener for Scancell Holdings plc (SCNLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Scancell Holdings plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Scancell Holdings plc (SCNLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Scancell Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Scancell Holdings plc's PE Ratio?

How is the PE Ratio calculated for Scancell Holdings plc (SCNLF)?

What is the highest PE Ratio for Scancell Holdings plc (SCNLF)?

What is the 3-year average PE Ratio for Scancell Holdings plc (SCNLF)?

What is the 5-year average PE Ratio for Scancell Holdings plc (SCNLF)?

How does the current PE Ratio for Scancell Holdings plc (SCNLF) compare to its historical average?